However, there is always variation based on the specifics of your member population
Contact for further information Media: Liz Skrbkova (US) +1 609 917 0632 (Mobile) [email protected] Jamie Bennett (US) +1 640 250 1881 (Mobile) [email protected] References Ozempic (semaglutide) injection [package insert]
Diabetes 63:24862497 Nauck MA, Petrie JR, Sesti G et al (2016) A phase 2, randomized, dose-finding study of the novel once-weekly human GLP-1 analog, semaglutide, compared with placebo and open-label liraglutide in patients with type 2 diabetes
The starting dose is subtherapeutic for most people
If you are changing your treatment plan If your current treatment plan is not working, your doctor will consider changing to a new treatment, such as Ozempic